A Multicenter Phase II Study Of BMS 247550 [ixabepilone] (Epothilone B Analogue) In Indolent Lymphoproliferative Disorders

Trial Profile

A Multicenter Phase II Study Of BMS 247550 [ixabepilone] (Epothilone B Analogue) In Indolent Lymphoproliferative Disorders

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2013

At a glance

  • Drugs Ixabepilone (Primary)
  • Indications Lymphoproliferative disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jul 2007 Status changed from in progress to completed.
    • 05 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top